ArticlePembrolizumab-Induced Bullous Pemphigoid: Navigating Diagnostic Challenges and Treatment ResistanceAuthor:Sara Ferguson, MD Publish date: June 30, 2026Bullous pemphigoid (BP) is an autoimmune blistering disorder characterized by the development of tense subepidermal blisters and erosions primarily... Read More